02415 MEDSCI
- 0.660
- +0.030+4.76%
MEDSCI News
MedSci Healthcare Advances Share Award Scheme
Meihs-kang (02415): The trustee purchased a total of 100,000 shares under the stock incentive plan.
Mei's Health (02415) announced that on September 11, 2024, the trustee purchased a total of 10 shares from the Hong Kong Stock Exchange.
Meihsin Health (02415) fell 58.40%, now at 1.150 yuan, hitting a new 52-week low.
As of 11:47, Healthmes (02415) fell 58.40% from the previous closing price to HKD 1.150, hitting a 52-week low. The volume was 1.0665 million shares with a turnover of HKD 1.1986 million.
Market Cool On MedSci Healthcare Holdings Limited's (HKG:2415) Revenues Pushing Shares 34% Lower
MEDSCI: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2024
HK stocks fluctuate | Mason(02415) hits a new low, dropping over 5%, expecting a maximum net profit decline of 0.5 million yuan in the first half of the year. The company may be removed from the Hong Kong stock connect.
Following the profit warning, Meinian Health (02415) fell by more than 5%, hitting a new all-time low of 1.42 Hong Kong dollars. The market cap has evaporated nearly 90% from its historical high. As of the time of writing, it is down 5.33% at 1.42 Hong Kong dollars with a turnover of 2.236 million Hong Kong dollars.
MedSci Healthcare Signals Profit Decline but Stays Optimistic
Mason Health (02415.HK): It is expected that the mid-term net profit will decrease but the gross margin will increase. The company will maintain profitability.
On August 26th, JCHI Health (02415.HK) announced that for the six months ended June 30, 2024 ('the reporting period'), it is expected that the net profit for the reporting period will decrease to no more than RMB 0.5 million from RMB 11.9 million for the six months ended June 30, 2023 ('the corresponding period'). This is mainly due to (i) the temporary delay in the recognition of revenue from the Precision Omni-Channel Marketing Solutions and Real-World Clinical Research Solutions projects due to the postponed execution of the projects, resulting in a decrease in group revenue for the reporting period compared to the corresponding period; and (ii) there were no convertible redeemable preferred shares in the corresponding period.
MEDSCI: INSIDE INFORMATIONPROFIT WARNING
Calculating The Intrinsic Value Of MedSci Healthcare Holdings Limited (HKG:2415)
MedSci Healthcare Prepares for Key Board Meeting
Meihsing Health (02415.HK) plans to hold a board of directors meeting on August 30 to review its interim performance.
Mei's Health (02415.HK) announced that the board of directors meeting will be held on August 30, 2024 (Friday), including the consideration and approval of the group's interim performance report for the six months ending on June 30, 2024, and the proposal to distribute interim dividends (if any), as well as handling other matters.
MEDSCI: DATE OF BOARD MEETING
After being removed from the Hang Seng Composite Index, the stocks plummeted collectively. Dingdang Health (09886) fell by 14.55%. CICC is expected to be removed from the Hong Kong Stock Connect.
Kingwu Finance News | Latest quarterly inspection results of Hang Seng Index companies have been released. Some shares that were removed from the Hang Seng Composite Index were under pressure. Dingdong Health (09886) fell by 14.55%, Messrs Medical (02415) by 14.35%, Ningo Media (09857) by 14.15%, Yidian Cloud (02416) by 13.49%, Saint-nor Pharmaceutical (02257) by 13.3%, Alli International Education Leasing (01563) by 10.71%, Silurian Medical Co., Ltd. (01244) by 9%, Chinasouthcity (01668) by 7.26%, EC Healthcare (02138) by 2.
MeisHealth's affiliated biopharmaceutical valley has reached a strategic cooperation agreement with Weigao Group.
Mei's Health (02415) issued an announcement that its subsidiary, Shanghai Chungu Biomedical Technology Co., Ltd. (Biological Valley) has officially reached a strategic cooperation with Weigh Group Co., Ltd. (Weigh Group) recently. Both parties will cooperate through the joint construction of multiple alliances such as the media cooperation promotion, park investment promotion, and industry sharing and exchange strategic services alliance, market acceleration service strategic alliance, scientific research and innovation alliance, and financial services innovation alliance. By stimulating more local innovation vitality, deeply promoting the influence of Weigh Park and Weigh Group's quality products, and helping Weigh Group's core competitiveness in the industry to continue to rise. The Chinese medical industry is right.
MedSci Healthcare Announces Strategic Partnership
Mei's Health (02415.HK) subsidiary Biovalley has reached a strategic cooperation with Weigao Group.
On July 19th, Health Industry Mesooon Inc. (02415.HK) announced that its subsidiary Shanghai Chungu Biomedical Technology Co., Ltd. ("Chungu Biomedical") has officially reached a strategic cooperation with Weigao Group Co., Ltd. ("Weigao Group"). The two parties will cooperate in multiple alliances, such as media promotion, park investment promotion, and strategic service alliances for industry sharing and exchange, market acceleration services, scientific research and innovation alliances, and financial services and innovation alliances. They will work together to stimulate more local innovation energy, deepen the influence of Weigao Park and the high-quality products of Weigao Group, and help Weigao Group's core competencies in the industry.
Express News | MedSci Healthcare - Entry of Strategic Cooperation Between Valley Bio and Weigao Holding
Lacklustre Performance Is Driving MedSci Healthcare Holdings Limited's (HKG:2415) 31% Price Drop
MedSci Healthcare Co-CEO Steps Down; Successor Named
Analysis
Price Target
No Data
No Data